Metabolomic Diagnostics, has secured an additional €1.6 million in from investors to help complete PrePsia™, its new screening test for pre-eclampsia in first time pregnant mothers. This latest funding round is supported by existing investors, SOSventures, Enterprise Equity and Enterprise Ireland as well as a number [...]
Metabolomic Diagnostics have expanded its team by recruiting Paloma Muñiz Ortea and Leslie Brown. Ms. Muñiz Ortea is our R&D Product Development manager. Paloma is trained as an analytical chemist and holds a PhD from the Cork Institute of Technology where she developed analytical methods [...]
As a nationally recognized health observance, Preeclampsia Awareness Month presents the perfect opportunity for the Preeclampsia Foundation to offer education and events that will increase awareness of this life-threatening hypertensive disorder of pregnancy, which occurs in up to eight percent of all pregnancies. The Preeclampsia [...]
Metabolomic Diagnostics’ Director of R&D, Dr. Robin Tuytten will attend the SRI’s 63rd Annual Scientific Meeting, which will take place at the Palais des congres de Montreal in Montreal, QC, Canada, from March 16 – 19, 2016. Prof. Louise Kenny of the Irish Centre for Fetal [...]
Yesterday afternoon, Metabolomic Diagnostics’ Director of R&D, Dr. Robin Tuytten, hosted a complimentary webinar on Stratification for Pre-eclampsia: Lessons Learned from Translation of a Metabolomics Discovery to a Robust LC-MS-20160229 1400-1. The event was hosted by the AACC and sponsored by Agilent Technologies. If you missed [...]
On February 29th, join Metabolomic Diagnostics’ Director of R&D, Dr. Robin Tuytten, for an informative look at what it takes to translate the results of an unbiased metabolomics discovery study into a robust analytical pipeline centered around a research-use-only, semi-quantitative LC-MS/MS methodology. Registration is complimentary. [...]
Professor Louise Kenny, inventor of Metabolomic Diagnostics revolutionary technology recently spoke to the Health Independent about being a Mother, a Doctor, and an Innovator. The article is reproduced here: Maternal and perinatal disease account for 10 per cent of the global disease burden, yet only [...]
At the recent International Society For The Study Of Hypertension in Pregnancy Congress in Budapest, Metabolomic Diagnostics submitted a Poster outlining the team’s ongoing Mass Spec Research. We were delighted when our research was recognised by the organising committee with an award as one of [...]
MASS SPECTROMETRIST – BIOMARKER VERIFICATION AND VALIDATION Project/Job Description Metabolomic Diagnostics Ltd is an early stage biotechnology company located in Cork, Ireland. The company is developing novel and innovative tests to predict pregnancy related complications prior to their clinical manifestation. The technology is based [...]
Irish SME wins EU funding for novel test to detect preeclampsia. ec.europa.eu